American Society Of Hypertension Assumes Charge Of Hypertension Guideline Development
NEW YORK, June 20, 2013 /PRNewswire/ -- A recent shift in the National Heart, Lung and Blood Institute (NHLBI) health education agenda has prompted hypertension-related organizations to spearhead the development and implementation of national hypertension practice guidelines.
As published in CIRCULATION today, the NHLBI announced it will no longer develop national clinical practice guidelines, like the highly anticipated Joint National Committee Reports on the Prevention, Detection, and Treatment of High Blood Pressure. With a renewed, exclusive focus on producing knowledge and evidence syntheses on the latest scientific research in cardiovascular medicine, the NHLBI will now generate systematic reviews to enable partner organizations in the development of their own clinical practice guidelines.
Given this paradigm shift, the American Society of Hypertension, Inc. (ASH) will adjust its own strategic model to now include the development and implementation of guidelines on the clinical treatment of Hypertension. "While ASH understands that the guideline will not be published as a clinical recommendation but instead as a summary of the evidence, the Society welcomes the opportunity to translate the evidence into practical treatment strategies in collaboration with related organizations," noted William B. White, MD, ASH President.
ASH anticipates that this new responsibility will require enormous coordinated efforts on behalf of the Society, its stakeholders, and its partners to ensure the development of high-quality; evidence-based clinical practice guidelines that take into account the diversity of perspectives and expertise in the hypertension arena, resulting in improved outcome for patients with hypertension.About the American Society of Hypertension, Inc. The American Society of Hypertension, Inc. (ASH) is the largest U.S. professional organization of scientific investigators and healthcare professionals committed to eliminating hypertension and its consequences. ASH is dedicated to promoting strategies to prevent hypertension and to improving the care of patients with hypertension and associated disorders. The specific focus of the Society is to translate current research findings on hypertension into effective treatment strategies, in order to better address the needs of hypertensive patients. For more information, please visit www.ash-us.org. SOURCE American Society of Hypertension, Inc. (ASH)
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts